SEBI Registered Research Analyst •
BSE Enlistment 6682
Finchemist Solutions (Research Analyst, SEBI Registration No.: INH000023117, BSE Enlistment No.: 6682) is a SEBI-Registered Research Analyst entity operating strictly in accordance with the SEBI (Research Analysts) Regulations, 2014. We maintain the highest standards of ethical conduct, transparency, and regulatory compliance in all research activities.
SEBI Registered Research Analyst [INH000023117]
All research insights are prepared independently and in-house, without any third-party influence, ensuring objectivity and research integrity. We maintain the highest standards of ethical conduct, transparency, and regulatory compliance in all research activities.
Our recommendations are based on a combination of fundamental and technical research frameworks, providing a balanced and multidimensional market view. We emphasize risk management, suitability, and evidence-based analysis. Every research report includes data-supported rationales to help investors take informed decisions. We do not provide assured returns, unsolicited tips, or unrealistic claims, in line with SEBI guidelines.
SEBI Registration No: INH000023117
Verify Registration on BSE IndiaProviding Independent, Research-Based Analysis and Risk-Aware Trading and Investment Insights
Choose the Comfotable Pricing Plans for your Trading and Investment Decisions
SEBI Registration No: INH000023117 | All services are for educational & informational purposes only.
SEBI Registered Research Analyst
Disclosures & Disclaimer
Finchemist Solutions (SEBI Registration No. INH000023117)
Finchemist Solutions is registered with the Securities and Exchange Board of India (SEBI) as a Research Analyst under Registration No. INH000023117.
There are no pending material litigations or legal proceedings against the Research Analyst.
As on date, no penalties or directions have been issued by SEBI under the SEBI Act or any Regulations made thereunder against the Research Analyst relating to Research Analyst services.
The Research Analyst or any of its officers/employees does not trade in securities which are the subject matter of recommendation.
There are no actual or potential conflicts of interest arising from any connection to or association with any issuer of products/securities, including any material information or facts that might compromise objectivity or independence in carrying out Research Analyst services. Such conflicts, if they arise in future, shall be disclosed to the client as and when they occur.
The Research Analyst or its employees/associates have not received any compensation from the company which is the subject matter of recommendation.
The Research Analyst or its employees/associates have not managed or co-managed the public offering of any company.
The Research Analyst or its employees/associates have not received any compensation for investment banking, merchant banking, or brokerage services from the subject company.
The Research Analyst or its employees/associates have not received any compensation for products or services other than research from the subject company.
The Research Analyst or its employees/associates have not received any compensation or other benefits from the subject company or any third party in connection with the research report/recommendation.
The subject company was not a client of the Research Analyst or its employees/associates during the twelve months preceding the date of recommendation services provided.
The Research Analyst or its employees/associates have not served as an officer, director, or employee of the subject company.
The Research Analyst has not been engaged in market-making activity of the subject company.
Analysts/partners may hold personal/proprietary positions in securities covered in research reports. Any such holding will be specifically disclosed at the time of publication.
A "Chinese Wall" policy is maintained to avoid conflicts between research activities and personal/proprietary trading.
No part of the compensation of Research Analysts is related to the recommendation or views expressed in research reports.
Compensation of analysts is not linked to investment banking or merchant banking activities.
All research material, reports, and data are the property of Finchemist Solutions.
Unauthorized use, copying, or distribution is strictly prohibited.
Securities investments are subject to market risks and price fluctuations.
Past performance of securities or recommendations does not guarantee future results.
Investors are advised to make independent investment decisions and/or consult their financial advisor.
This research report has been prepared by the Research Analyst/Research Entity using publicly available information and data believed to be reliable. Artificial Intelligence (AI) tools may have been used solely for purposes such as data processing, drafting assistance, grammar correction, or summarization.
No AI system has made any investment recommendations, valuations, or forecasts contained in this report. All analysis, opinions, and conclusions expressed are solely those of the Research Analyst and have been independently reviewed and approved in accordance with applicable regulatory standards (such as SEBI Research Analyst Regulations, 2014).
"Investment in securities market are subject to market risks. Read all the related documents carefully before investing."
"Registration granted by SEBI, and certification from NISM in no way guarantee performance of the Research Analyst or provide any assurance of returns to investors."
In case of grievances, clients may write to:
Grievance Officer / Compliance Officer
Name: Sagar Vijay Agrawal
Designation: Compliance Officer
Email: grievance@finchemist.com
Phone: +91 8149725003
Address: FINCHEMIST SOLUTIONS, Samruddhi Namrata Apartment, Flat no-8, 4th floor, Plot no-4, New Pandit Colony, Nashik 422002, Maharashtra, India
If unsatisfied with the response, complaints may be escalated to SEBI via the SCORES Portal: scores.sebi.gov.in
SEBI Registration No: INH000023117
Registered on: 28 June 2024
Data of the month ending October, 2025
| Sr No. | Received from | Pending at the end of last month | Received | Resolved* | Total Pending# | Pending complaints > 3 months | Avg Resolution Time^ (in days) |
|---|---|---|---|---|---|---|---|
| 1 | Directly from investor | 0 | 0 | 0 | 0 | 0 | 0 |
| 2 | SEBI (Scores) | 0 | 0 | 0 | 0 | 0 | 0 |
| 3 | Other Sources (if any) | 0 | 0 | 0 | 0 | 0 | 0 |
| Grand Total | 0 | 0 | 0 | 0 | 0 | 0 | |
Grand Total Number of complaints received during month against the RA due to impersonation by some other entity: _____
Note: In case of any complaints received against the RA due to impersonation of the RA by some other entity, the RA may adjust the number of such complaints from total number of received/resolved complaints while preparing the above table. Further, RA must close such impersonation-related complaints after following the due process as specified by SEBI / RAASB.
* Inclusive of complaints of previous months resolved in the current month.
# Inclusive of complaints pending as on the last day of the month.
^ Average Resolution Time is the sum total of time taken to resolve each complaint (in days) in the current month divided by total number of complaints resolved in the current month
| Sr No. | Month | Carried forward from previous month | Received | Resolved* | Pending# |
|---|---|---|---|---|---|
| 1 | November-2024 | 0 | 0 | 0 | 0 |
| 2 | December-2024 | 0 | 0 | 0 | 0 |
| 3 | January-2025 | 0 | 0 | 0 | 0 |
| 4 | February-2025 | 0 | 0 | 0 | 0 |
| 5 | March-2025 | 0 | 0 | 0 | 0 |
| Grand Total | 0 | 0 | 0 | ||
* Inclusive of complaints of previous months resolved in the current month.
# Inclusive of complaints pending as on the last day of the month.
| Sr No. | Year | Pending at the end of last month | Received | Resolved* | Pending# |
|---|---|---|---|---|---|
| 1 | 2021–22 | 0 | 0 | 0 | 0 |
| 2 | 2022–23 | 0 | 0 | 0 | 0 |
| 3 | 2023–24 | 0 | 0 | 0 | 0 |
| 4 | 2024-25 | 0 | 0 | 0 | 0 |
| Grand Total | 0 | 0 | 0 | 0 | |
* Inclusive of complaints of previous years resolved in the current year.
# Inclusive of complaints pending as on the last day of the year.
FinChemist Solutions
SEBI Registration No: INH000023117
Zero pending complaints as on date
FinChemist is committed to addressing and respecting every concerns through a fair and transparent grievance policy.
| Details of Designation | Name | Address | Contact No. | Email ID | Working Hours when a complainant can call |
|---|---|---|---|---|---|
| Customer Care Head of Customer care Compliance Officer |
Mr. Sagar Agrawal | Aasavari Chambers, Office No. 214, Second Floor, College Road, Nashik 422002 | +918149725003 | grievance@finchemist.com | 10.00 AM to 5.30 PM |
| CEO Principal Officer |
Mr. Vinay Kulkarni | Aasavari Chambers, Office No. 214, Second Floor, College Road, Nashik 422002 | +917066177155 | grievance@finchemist.com | 10.00 AM to 5.30 PM |
Step 1: The client should first contact the RA using the details on its website www.finchemist.com or following contact details:
• Contact Mr. Sagar Agrawal – grievance@finchemist.com
Step 2: If the resolution is unsatisfactory, the client can also lodge grievances through SEBI's SCORES platform at scores.sebi.gov.in
Step 3: The client may also consider the Online Dispute Resolution (ODR) through the Smart ODR portal at https://smartodr.in
FinChemist Solutions
SEBI Registration No: INH000023117
Securities and Exchange Board of India (SEBI)
Vision: Invest with knowledge & safety.
Mission: Every investor should be able to invest in right investment products based on their needs, manage and monitor them to meet their goals, access reports and enjoy financial wellness.
Onboarding of Clients
Disclosure to Clients
Other Commitments
1. Filing a Complaint with the Research Analyst
Investors can lodge grievances directly with the Research Analyst. The Research Analyst shall strive to redress grievances immediately, but not later than 21 days from receipt.
2. Filing a Complaint via SCORES / RAASB
SCORES 2.0: SEBI's centralized web-based grievance redressal system https://scores.sebi.gov.in
First review: by RAASB (Research Analyst Administration and Supervisory Body)
Second review: by SEBI
Email: Complaint can also be sent to the designated email ID of RAASB.
3. SMART ODR (Online Dispute Resolution)
If unsatisfied with the resolution, investors may file the complaint on the SMARTODR platform for online conciliation or arbitration.
4. Physical Complaints
Investors may also send complaints to:
Office of Investor Assistance and Education,
Securities and Exchange Board of India,
SEBI Bhavan, Plot No. C4-A, 'G' Block,
Bandra-Kurla Complex, Bandra (E), Mumbai – 400051
Issued in accordance with SEBI guidelines for Research Analysts (Updated as per latest SEBI circular requirements)
FinChemist Solutions
SEBI Registered Research Analyst • INH000023117
FinChemist upholds clear and fair terms and conditions to ensure transparency and mutual understanding.
Finchemist Solutions (SEBI Registration No. INH000023117)
Disclosure of Minimum Mandatory Terms and Conditions to Clients
(As per SEBI (Research Analysts) Regulations, 2014 and SEBI Circulars)
By accepting delivery of the research service, the client confirms that he/she has elected to subscribe to the research services of the Research Analyst (RA) at his/her sole discretion. The RA confirms that research services shall be rendered in accordance with the applicable provisions of the SEBI (Research Analysts) Regulations, 2014 ("RA Regulations") and other applicable laws.
The RA and the client shall be bound by the SEBI Act, 1992 and all applicable rules, regulations, and circulars issued by SEBI, including the RA Regulations and relevant Government notifications, as may be in force from time to time.
The client shall furnish all required details in full, as may be mandated by the RA, supported by documents and information as may be prescribed by SEBI or the Research Analyst Administration and Supervisory Body (RAASB) from time to time. The RA shall collect, verify, upload, and maintain KYC records of clients with the SEBI-registered KYC Registration Agency (KRA) in accordance with SEBI requirements.
Client Declaration:
"I/We have read and understood the terms and conditions applicable to a Research Analyst as defined under Regulation 2(1)(u) of the SEBI (Research Analysts) Regulations, 2014, including the fee structure. I/We are subscribing to the research services for our own benefit and consumption, and any reliance placed on the research report provided by the Research Analyst shall be as per our own judgement and assessment of the conclusions contained therein. I/We understand that:
Declaration by the Research Analyst:
If RA is an individual: The RA declares that he/she is not engaged in any additional professional or business activities on a whole-time or executive basis which may interfere with or influence the independence of research or recommendations.
The client shall pay the agreed fees and statutory charges as applicable to the RA through permitted modes such as cheque, bank transfer, or UPI. All payments shall be made in accordance with the manner and mechanisms specified by SEBI or RAASB.
Investments in securities are subject to market risks, including possible loss of principal. Past performance is not indicative of future returns. (The RA shall include a detailed statement covering standard investment risks.)
The RA shall comply with SEBI's applicable regulations and circulars relating to identification, disclosure, and mitigation of any actual or potential conflict of interest. (The RA shall include a detailed statement of mandatory disclosures here.)
The RA may suspend or terminate research services in case of suspension or cancellation of its SEBI registration. In such case, the RA shall refund the residual amount to the client on a pro-rata basis from the effective date of suspension/cancellation until the end of the subscription period. If suspension continues beyond 60 (sixty) days or registration is cancelled, refund shall be made accordingly.
Clients may escalate grievances such as non-receipt of research reports, missing pages, download issues, or any service deficiencies to the designated person of the RA.
For complaints or grievances, clients may contact:
Grievance Officer / Compliance Officer:
Name: Sagar Vijay Agrawal
Designation: Compliance Officer
Email: grievance@finchemist.com
Phone: +91 8149725003
Address: FINCHEMIST SOLUTIONS, Samruddhi Namrata Apartment, Flat no-8, 4th floor, Plot no-4, New Pandit Colony, Nashik 422002, Maharashtra, India
The RA shall resolve grievances within 7 (seven) business days or as prescribed by SEBI.
Escalation Steps:
Any additional voluntary clauses included by the RA must not contravene SEBI's rules, regulations, or circulars. Any amendment to such clauses shall be preceded by at least 15 days' prior notice to clients.
Clients are advised to go through SEBI's "Do's and Don'ts while dealing with Research Analysts" as per SEBI Master Circular No. SEBI/HO/MIRSD-POD-1/P/CIR/2024/49 dated May 21, 2024, or as updated from time to time.
The RA shall guide clients regarding the optional Centralised Fee Collection Mechanism (CeFCoM) for payment of fees, managed by BSE Limited (RAASB).
FinChemist Solutions
SEBI Registration No: INH000023117
Finchemist Solutions (SEBI Registration No. INH000023117)
This Privacy Policy explains how Finchemist Solutions ("we", "our", "us") collects, uses, stores, and protects the personal information of clients, prospective clients, and users of our research services, in compliance with applicable laws and SEBI (Research Analysts) Regulations, 2014.
We may collect and process the following categories of information:
Your information is collected and used for:
We do not sell, trade, or rent personal information to third parties.
We may share information only in the following cases:
We implement reasonable technical and organizational measures to safeguard your personal data against unauthorized access, misuse, alteration, or loss.
We retain personal information for as long as necessary:
Clients have the right to:
For any concerns regarding this Privacy Policy or your personal information, you may contact:
Grievance Officer / Compliance Officer:
Name: Sagar Vijay Agrawal
Designation: Compliance Officer
Email: grievance@finchemist.com
Phone: +91 8149725003
Address: FINCHEMIST SOLUTIONS, Samruddhi Namrata Apartment, Flat no-8, 4th floor, Plot no-4, New Pandit Colony, Nashik 422002, Maharashtra, India
This Privacy Policy may be updated periodically to reflect changes in regulatory requirements or internal practices. Any updates will be published on our website.
FinChemist Solutions
SEBI Registration No: INH000023117
FinChemist Solutions
SEBI Registration Number: INH000023117 | BSE Enlistment: 6682
SEBI Registration Number: INH000023117 | BSE Enlistment: 6682
Address:
FINCHEMIST SOLUTIONS,
Aasavari Chambers, Office No. 214,
Second Floor, College Road,
Nashik 422002
This document outlines the Anti-Money Laundering (AML) Policy of FinChemist Solutions, a SEBI-registered Research Analyst (Firm Registration Number: INH000023117, BSE Enlistment: 6682). This policy complies with the Prevention of Money Laundering Act, 2002 (PMLA), its rules, and SEBI guidelines, including the SEBI Circular dated February 17, 2025. It ensures that FinChemist Solutions's operations, including services like Intraday Trading, Swing Trading, Research Reports, and IPO Analysis, are not misused for money laundering or terrorist financing activities.
The objective of this policy is to establish a robust framework for detecting and reporting suspicious transactions while ensuring compliance with applicable laws and regulations. This policy covers:
No accounts will be opened in fictitious or anonymous names.
Accounts will not be opened if adequate client due diligence (KYC) measures, including PAN card verification, cannot be applied.
All clients must be KYC registered and provide valid documentation as mandated by SEBI.
Client identities will be verified against SEBI's list of banned persons/entities and stock exchange records.
Risk assessments will be conducted, including checks against sanctions lists maintained by United Nations Security Council Resolutions.
Client identities will be verified using reliable sources to ensure accurate and complete KYC details, including PAN card and address proof.
Any discrepancies in documentation will be escalated to the Compliance Officer for resolution.
Client records will be updated regularly to comply with SEBI's requirement for KYC updates by June 30, 2025, for existing clients.
All client records, including KYC documents and transaction details, will be maintained for a minimum of 10 years or until the resolution of any regulatory action, as per SEBI and PMLA guidelines. Records will be securely stored at the office address mentioned above.
Monitoring Transactions
Transactions involve service fees accepted only through banking channels. No cash transactions are permitted. All transactions are monitored for suspicious patterns.
Reporting Suspicious Transactions
Suspicious transactions are reported to the Compliance Officer and then to FIU-IND. Confidentiality is maintained.
Onboarding Staff: Adhere to KYC/CDD procedures and report suspicious activity.
FinChemist Solutions
SEBI Registration No: INH000023117
FinChemist Solutions
SEBI Registered Research Analyst (INH000023117)
FINCHEMIST SOLUTIONS,
Aasavari Chambers, Office No. 214,
Second Floor, College Road,
Nashik 422002
FinChemist Solutions
SEBI Registration No: INH000023117
Our experienced research team delivers comprehensive analysis and research-based insights, helping clients make informed investment decisions through detailed market research.
Tap the small WhatsApp icon on each card to connect directly
Copyright © 2026 FinChemist Solutions